Transforming Bulk Harvest Testing into a Strategic Asset for Biomanufacturing Success
This whitepaper discusses the importance of unprocessed bulk harvest (UBH) testing in biomanufacturing, highlighting its role in ensuring product quality, safety, and consistency. It emphasizes the need for robust testing to detect contaminants, mitigate risks, and support regulatory compliance, ultimately contributing to the reliability and efficiency of biologic production processes.
Additional insights:
- Critical biomanufacturing checkpoint ensures the quality and safety of biologic products prior to downstream processes.
- Contaminant detection: provides the highest probability of detecting adventitious agents while contaminants are still present, reducing potential risks before purification.
- Regulatory compliance: Mandatory testing at the UBH stage aligns with regulatory requirements, supporting compliance with guidelines set by agencies like the FDA and EMA.
- Risk mitigation: Early identification of contamination helps prevent costly failures, safeguards manufacturing capacity, and ensures robust biomanufacturing processes.
- Comprehensive testing services: Options include adventitious virus assays, mycoplasma testing, sterility assessments, and electron microscopy for thorough analysis.